NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,147 | +253.3% | 35,506 | +241.2% | 0.00% | – |
| Q2 2023 | $5,986 | -18.5% | 10,406 | -0.5% | 0.00% | – |
| Q1 2023 | $7,349 | -68.8% | 10,456 | +0.3% | 0.00% | – |
| Q4 2022 | $23,565 | -64.8% | 10,427 | -50.3% | 0.00% | – |
| Q3 2022 | $67,000 | -15.2% | 20,977 | +0.8% | 0.00% | – |
| Q2 2022 | $79,000 | -54.1% | 20,818 | -34.9% | 0.00% | – |
| Q1 2022 | $172,000 | -61.2% | 31,969 | -2.4% | 0.00% | – |
| Q4 2021 | $443,000 | -20.0% | 32,767 | +6.3% | 0.00% | -100.0% |
| Q3 2021 | $554,000 | +0.5% | 30,832 | -4.0% | 0.00% | 0.0% |
| Q2 2021 | $551,000 | -12.5% | 32,132 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $630,000 | +19.5% | 31,495 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $527,000 | +23.1% | 31,010 | +20.2% | 0.00% | 0.0% |
| Q3 2020 | $428,000 | -33.8% | 25,792 | -7.7% | 0.00% | 0.0% |
| Q2 2020 | $647,000 | +44.7% | 27,952 | +11.7% | 0.00% | 0.0% |
| Q1 2020 | $447,000 | -4.3% | 25,020 | +15.6% | 0.00% | 0.0% |
| Q4 2019 | $467,000 | +31.5% | 21,640 | +11.0% | 0.00% | 0.0% |
| Q3 2019 | $355,000 | -58.0% | 19,492 | -17.9% | 0.00% | -50.0% |
| Q2 2019 | $845,000 | +2.3% | 23,736 | -3.5% | 0.00% | 0.0% |
| Q1 2019 | $826,000 | +32.2% | 24,597 | +29.4% | 0.00% | 0.0% |
| Q4 2018 | $625,000 | +80.6% | 19,005 | +235.0% | 0.00% | +100.0% |
| Q3 2018 | $346,000 | +31.1% | 5,673 | +4.8% | 0.00% | 0.0% |
| Q2 2018 | $264,000 | -26.5% | 5,413 | +60.1% | 0.00% | 0.0% |
| Q1 2018 | $359,000 | – | 3,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |